Modalis Therapeutics Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Net Income	-1,316	-2,390	-2,707	-745	-439	Upgrade
Depreciation & Amortization	-	-	123	77	57	Upgrade
Loss (Gain) From Sale of Assets	-	38	997	2	-	Upgrade
Other Operating Activities	-15	1	1	488	-	Upgrade
Change in Accounts Receivable	-	-	-	-	6	Upgrade
Change in Accounts Payable	-119	49	9	51	-31	Upgrade
Change in Other Net Operating Assets	18	48	-318	-620	31	Upgrade
Operating Cash Flow	-1,432	-2,254	-1,895	-747	-376	Upgrade
Capital Expenditures	-	-39	-197	-107	-16	Upgrade
Sale (Purchase) of Intangibles	-	-	-	-	-814	Upgrade
Other Investing Activities	-	-	12	278	-	Upgrade
Investing Cash Flow	-	-39	-185	171	-830	Upgrade
Long-Term Debt Issued	694	488	-	-	-	Upgrade
Long-Term Debt Repaid	-37	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	657	488	-	-	-	Upgrade
Issuance of Common Stock	2,395	735	71	72	2,798	Upgrade
Other Financing Activities	-8	-7	-8	-	-21	Upgrade
Financing Cash Flow	3,044	1,216	63	72	2,777	Upgrade
Foreign Exchange Rate Adjustments	79	27	14	17	-6	Upgrade
Miscellaneous Cash Flow Adjustments	-	1	-	2	-1	Upgrade
Net Cash Flow	1,691	-1,049	-2,003	-485	1,564	Upgrade
Free Cash Flow	-1,432	-2,293	-2,092	-854	-392	Upgrade
Free Cash Flow Margin	-	-	-5230.00%	-85400.00%	-114.62%	Upgrade
Free Cash Flow Per Share	-31.05	-74.05	-71.87	-29.70	-14.88	Upgrade
Cash Interest Paid	3	4	6	-	-	Upgrade
Cash Income Tax Paid	1	1	1	1	-	Upgrade
Levered Free Cash Flow	-890.63	-1,418	-1,402	-787	-1,065	Upgrade
Unlevered Free Cash Flow	-885.63	-1,408	-1,399	-786.38	-1,065	Upgrade
Change in Net Working Capital	50	-112	36	-18	43	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.